Iris Lavon

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Integrating androgen signaling tumor dependency with host neuroendocrine immunity for glioblastoma therapies.

Integrating androgen signaling tumor dependency with host neuroendocrine immunity for glioblastoma therapies.

Journal: Neuro-oncology
Published: July 03, 2026

DNA methylation-based deconvolution study of glioblastoma heterogeneity and identification of cell compositions associated with patient survival.

DNA methylation-based deconvolution study of glioblastoma heterogeneity and identification of cell compositions associated with patient survival.

Journal: Neuro-oncology advances
Published: October 25, 2025

Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms.

Investigating Expression Dynamics of miR-21 and miR-10b in Glioblastoma Cells In Vitro: Insights into Responses to Hypoxia and Secretion Mechanisms.

Journal: International journal of molecular sciences
Published: June 26, 2024

Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants.

Intracranial Assessment of Androgen Receptor Antagonists in Mice Bearing Human Glioblastoma Implants.

Journal: International journal of molecular sciences
Published: November 27, 2023

Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study.

Rapid Classification of Sarcomas Using Methylation Fingerprint: A Pilot Study.

Journal: Cancers
Published: July 25, 2023

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Journal: International journal of molecular sciences
Published: May 31, 2022

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.

Journal: Glia
Published: October 05, 2021

Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target.

Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target.

Journal: International journal of molecular sciences
Published: August 26, 2021

[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

Journal: Neuro-oncology advances
Published: March 19, 2021

QKI-V5 is downregulated in CNS inflammatory demyelinating diseases.

QKI-V5 is downregulated in CNS inflammatory demyelinating diseases.

Journal: Multiple sclerosis and related disorders
Published: September 12, 2019

Corrigendum to "Foxp3+ regulatory T cells expression in Neuromyelitis optica spectrum disorders" [Multiple Sclerosis and Related Disorders 30 (2019) 114-118].

Corrigendum to "Foxp3+ regulatory T cells expression in Neuromyelitis optica spectrum disorders" [Multiple Sclerosis and Related Disorders 30 (2019) 114-118].

Journal: Multiple sclerosis and related disorders
Published: April 17, 2019

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis.

Journal: Frontiers in immunology
Published: December 25, 2018
Showing 1-12 of 28

Last Updated: 09/26/2026